TRIS: Contingency Management App for Alcohol Use Disorder
Remote Treatment With Incentives for Sobriety (TRIS): A Randomized Controlled Trial of a Contingency Management App for Alcohol Use Disorder
1 other identifier
interventional
130
1 country
1
Brief Summary
Alcohol Use Disorder (AUD) is a major public health concern associated with substantial morbidity, mortality, and impaired social and occupational functioning. Contingency Management (CM) is an evidence-based behavioral intervention that provides incentives contingent on abstinence and has demonstrated effectiveness in the treatment of substance use disorders. This study will evaluate the efficacy of Tratamento Remoto com Incentivos à Sobriedade (TRIS), a Brazilian mobile health application that integrates a smartphone app with a Bluetooth-enabled breathalyzer (BACtrack) to deliver remote CM for AUD. Participants will be randomized to receive either standard outpatient treatment plus TRIS-based CM or standard outpatient treatment with remote alcohol monitoring only. The primary objective is to determine whether TRIS-based CM increases biochemically verified alcohol abstinence compared with standard outpatient treatment alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2025
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
July 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
July 30, 2026
December 1, 2025
1.4 years
December 15, 2025
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Days of Alcohol Abstinence
Number of days with verified abstinence based on three daily BrAC samples submitted via the BACtrack remote breathalyzer over the 12-week intervention period.
Up to 12 weeks
Secondary Outcomes (5)
Days without Heavy Alcohol Consumption
Up to 12 weeks
App Usability
Week 12 (end of intervention)
Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar)
Baseline (Week 0), weekly during Weeks 1-12, and follow-up at Weeks 16, 20, and 24.
Obsessive-Compulsive Drinking Scale (OCDS)
Baseline (Week 0), weekly during Weeks 1-12, and follow-up at Weeks 16, 20, and 24.
Treatment Adherence
Up to 12 weeks
Study Arms (2)
Contingency Management (CM) + Treatment as Usual (TAU)
EXPERIMENTALParticipants receive standard outpatient treatment plus 12 weeks of remote contingency management delivered through the TRIS mobile application. Participants submit three breath alcohol concentration (BrAC) samples daily using a Bluetooth-enabled breathalyzer and receive escalating monetary incentives contingent on alcohol-negative breath samples.
Treatment as Usual (TAU)
ACTIVE COMPARATORParticipants receive standard outpatient treatment for Alcohol Use Disorder and use the TRIS mobile application to submit three daily breath alcohol concentration (BrAC) samples using a Bluetooth-enabled breathalyzer. No monetary incentives are provided for alcohol-negative breath samples.
Interventions
Remote contingency management delivered through the TRIS mobile application. Participants submit three daily breath alcohol concentration (BrAC) samples using a Bluetooth-enabled BACtrack breathalyzer. Monetary incentives ranging from R$5.00 to R$15.00 per day are provided contingent on verified alcohol abstinence.
Standard outpatient treatment for Alcohol Use Disorder provided at the participating outpatient clinics. Participants also use the TRIS mobile application and a Bluetooth-enabled BACtrack breathalyzer for remote alcohol monitoring but do not receive contingency management incentives.
Eligibility Criteria
You may qualify if:
- Able to read and speak Portuguese.
- Provide signed informed consent.
- Age 18 to 70 years.
- Alcohol consumption within the past month.
- Current diagnosis of Alcohol Use Disorder (AUD).
- Seeking treatment for AUD at AME Vila Maria or Instituto Perdizes.
- Breath alcohol concentration (BrAC) of 0.00 at the time of consent.
- Own and be able to operate a smartphone with an active mobile service plan.
- Smartphone compatible with the Bluetooth frequency required for the BACtrack breathalyzer.
You may not qualify if:
- Crack cocaine use within the past 90 days.
- Any seizure episode within the past 12 months.
- Diagnosis of a psychotic disorder (DSM-5).
- Suicide attempt within the past two years.
- Any medical or psychiatric condition that may compromise safe participation, as determined by the study medical director.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IPER Research Center
São Paulo, São Paulo, 05021-001, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
André Miguel, PhD
Washington State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2025
First Posted
July 30, 2026
Study Start
February 19, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
July 30, 2026
Record last verified: 2025-12